Income Statement
SEASTAR MEDICAL HOLDING CORP
ICU
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
1.23 | 0.14 | - | - | - |
|
Cost of Revenue
|
0.05 | 0.00 | - | - | - |
|
Gross Profit
|
1.18 | 0.14 | - | - | - |
|
Operating Expenses
|
13.36 | 17.98 | 14.21 | 11.61 | 1.12 |
|
Research & Development
|
7.52 | 9.11 | 5.97 | 2.82 | - |
|
Selling, General & Administrative
|
5.84 | 8.87 | 8.24 | 6.60 | 1.12 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-12.18 | -17.84 | -14.21 | -11.61 | -1.12 |
|
Non-Operating Income
|
0.03 | 6.99 | 12.02 | 11.40 | - |
|
Interest Income
|
0.33 | 0.10 | - | - | 0.01 |
|
Interest Expense
|
- | 0.24 | 1.08 | 0.63 | - |
|
Other Non-Op Income / Expense
|
- | -6.99 | -12.02 | -11.40 | - |
|
Income Before Tax
|
-12.15 | -24.83 | -26.23 | -23.01 | - |
|
Income Tax Expense
|
0.00 | 0.00 | 0.00 | 0.00 | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-12.15 | -24.83 | -26.23 | -23.01 | 0.08 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-12.18 | -17.84 | -14.21 | -11.61 | -1.12 |
|
Earnings Per Share (Basic)
|
-5.86 | -6.63 | -1.21 | -2.80 | - |
|
Diluted EPS
|
- | -6.63 | -1.21 | -2.80 | - |
|
Weighted Average Shares
|
2.07 | 3.74 | 21.67 | 8.21 | - |
|
Diluted Weighted Avg Shares
|
- | 3.74 | 21.67 | 8.21 | - |
|
Comprehensive Income
|
- | - | - | - | - |